chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6 days post vax delayed type hypersensitivity w/hives plaques extensive over entire body; uncontrolled w/Pred; devel bronchoconstiction & angioedema & was treated w/Adrenalin in ER;  papular eruptions-painful;
ON 3-20-2021 PATIENT SPOUSE REPORTED THAT PATIENT HAD SUFFERED A STROKE APPROXIMATELY 2 HOURS AFTER THE SECOND DOSE ON 3-18-21.  SHE STATED THAT HE WAS CURRENTLY HOSPITALIZED.
Moderna COVID #3 vaccine given 11/11/21, lot #004F21A; pt had a positive COVID test on 11/22/21 while staying at a Home; pt also fell and had poor oral intake; 12/7/21 came to hospital with left hip fx; due to pt's fragile state, surgery was not attempted; placed on comfort care only; inpatient hospice; pt died in the hospital
pt was given DT booster & devel urticarial rash on extremities, face, back;
Patient reported experiencing throat discomfort. Patient assessed, Benadryl (diphenhydramine) given by mouth. Throat discomfort/tightening progressed. epinephrine administered by auto-injector on left thigh. Transported to Hospital by ambulance. Patient recovered well discharged home.
Neck pain both sides; Stiffness arm injected site; Soreness arm injected site; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain both sides), MUSCULOSKELETAL STIFFNESS (Stiffness arm injected site), VACCINATION SITE PAIN (Soreness arm injected site), CHILLS (Chills) and FATIGUE (Fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Kidney disorder, Diabetes, Acid reflux (esophageal) and Constipation.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced NECK PAIN (Neck pain both sides), MUSCULOSKELETAL STIFFNESS (Stiffness arm injected site), VACCINATION SITE PAIN (Soreness arm injected site), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form and NAPROXEN (MOTRIN [NAPROXEN]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, NECK PAIN (Neck pain both sides), MUSCULOSKELETAL STIFFNESS (Stiffness arm injected site), VACCINATION SITE PAIN (Soreness arm injected site), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.
Patient called the office to mention an adverse event. She states about a minute after receiving the shot, she noticed that her throat became sore and her chest began to hurt. She did not mention anything to the provider and waited the 20 minute waiting period. As she was driving home, she began to develop some shortness of breath and she felt that her throat was started to swell a little. When she got home, she took 1 dose of OTC Claritin and within in hour, she was feeling much better. She did not have to take any other medications and has not had any reactions since the vaccine.
Hives at injection site; Redness below the injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE URTICARIA (Hives at injection site) and VACCINATION SITE ERYTHEMA (Redness below the injection site) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Hives at injection site) and VACCINATION SITE ERYTHEMA (Redness below the injection site). At the time of the report, VACCINATION SITE URTICARIA (Hives at injection site) and VACCINATION SITE ERYTHEMA (Redness below the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment for the event included diphenhydramine HCL.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt presented to the ED from urgent care on 2/6/22 for bilateral feet swelling and shortness of breath.  BP was hypotensive, COVID + 1/25/22. Date of Admission: 02/06/2022    Currently on- O2 - Remdesivir-Yes; ABx-ceftriaxone, Azithromycin, _ for CAP;  AC-  DVT PPX w Heparin-in the setting of CKD 3; Steroids-Continue IV dexamethasone  Continue Neb Rx with RT and supportive symptomatic treatment.  mild CHF 55-60% EF. Pt discharged 2/10/22, previously vaccinated Pfizer 2/28/21, 3/21/21, 10/01/21.
No adverse effect reported; on patient received improperly stored VARIVAX; This spontaneous report as received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 22-AUG-2019, the patient was vaccinated with an improperly stored  dose of varicella virus vaccine live (oka/merck)(VARIVAX)  lot # S005078 expiration date 19-FEB-2021 or lot # R019237 expiration date 04-JUL-2020 (strength, dose, frequency and anatomical location were not provided) for prophylaxis. The reporter had not clear which lot # was given to the patient, since both lot # had temperature excursion. The varicella virus vaccine live (oka/merck)(VARIVAX) was reconstituted with properly stored sterile diluent. The administered doses of the vaccines were stored with the temperature  between -14 degrees centigrades to -10 degrees centigrades (mainly at -9.74 degrees centigrades), the time frame was unknown by reporter. There was a digital data logger involved, but there was no previous temperature excursion. No adverse effect reported.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 08-MAY-2018, the patient was vaccinated with an improperly stored dose of LIQUID PEDVAXHIB, lot # N022167, expiration date: 08-FEB-2020 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 5 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1806USA001505: US-009507513-1806USA009026: US-009507513-1806USA009027: US-009507513-1806USA009028: US-009507513-1806USA009029: US-009507513-1806USA009030: US-009507513-1806USA009031: US-009507513-1806USA009032: US-009507513-1806USA009033: US-009507513-1806USA009034: US-009507513-1806USA009035: US-009507513-1806USA009036: US-009507513-1806USA009037: US-009507513-1806USA009039: US-009507513-1806USA009040: US-009507513-1806USA009041: US-009507513-1806USA009042: US-009507513-1806USA009043: US-009507513-1806USA009044: US-009507513-1806USA009045: US-009507513-1806USA009046: US-009507513-1806USA009047: US-009507513-1806USA009048: US-009507513-1806USA009049: US-009507513-1806USA009050: US-009507513-1806USA009051: US-009507513-1806USA009052: US-009507513-1806USA009053: US-009507513-1806USA009054: US-009507513-1806USA009055: US-009507513-1806USA009056:
very slight to mild fever headache and tired; very slight to mild fever headache and tired; very slight to mild fever headache and tired; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 66-years-old female patient received second dose of bnt162b2 (BNT162B2, Pfizer biontech covid 19 vaccine), via an unspecified route of administration on 15Feb2021 (at the age of 66 years) (Batch/Lot Number: EL9266) as 2nd dose, single dose for covid-19 immunisation. The patient had no relevant medical history and no illness was reported at the time of vaccination. The patient's family members are immunocompromised. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (BNT162B2, Pfizer biontech covid 19 vaccine), via an unspecified route of administration on 25Jan2021 (at the age of 66 years) (Batch/Lot Number: El9262 ) as single dose for covid-19 immunisation. The patient did not receive any vaccination within 4 weeks prior to covid-19 vaccination. There were no additional vaccines administered on same date of the covid-19 vaccine. On an unspecified date in Feb2021, the patient ran very slight to mild fever headache and tired for 6-8 hours after second dose. It was reported that she and her husband both received the Pfizer biontech covid 19 vaccine. They received both doses back in January. She was going to visit family and the family members are immunocompromised, so they went to get antibody tested and they did not have antibodies to the vaccine and they are very concerned. she was tested for both the IGA and IGM and they were negative. She further confirmed that these were the results for both her and her husband. Laboratory tests included IGA, IGM and sars-cov-2 antibody test on an unspecified date and results were negative. Outcome of the event very slight to mild fever headache and tired was reported as recovered on an unknown date in Feb2021.
-acute and chronic nasal congestion  (from onset July 22, 2021 until today--non stop) -headaches (intermittent, strongest September-November 2021) -easily short of breath (October 2021 until today) -diarrhea (July-November 2021) -muscle/joint stiffness or ache (August-October 2021) -Neck stiffness/immobility (October 2021 until today) -Clammy/sweaty/chills feeling (intermittent August 2021 until today) -1 episode of acute SOB October 2021 (remedied with antibiotics)
RUPTURED CEREBRAL ANEURYSM AND SUBARRACHNOID HEMMORRAGE BILAT AND DEATH
Covid positive on 7/21/2021. Cough. Fever up to 104. Vomiting. Severe headache. Severe fatigue. Severe sore throat.
Stiff neck, sore neck, sore back, sore arm. Stiff neck and sore neck is still lasting up to 8 months even until booster shot. Had trigger point injection and massages. Taking flexeril and Motrin for pain. Some days really bad and cannot get out of bed.
Constant soreness and intermittent pain in right leg (back of knee); tingly sensations in lower right leg, primarily on shin; numb toes and right foot numb (without sitting on it etc.) 4 times in one week; unable to workout because of right leg weakness. Numbness in right hand several times in one week. As of week 3, blurriness in eyes during morning and evening, and light pressure on forehead.
expired typhim vi dose was administered with no other reported adverse event; Initial information received from on 22-Aug-2022 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves a 29 years old female patient to whom expired TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI] dose was administered with no other reported adverse event.   The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided.   On 22-Aug-2022, the patient received a 0.5ml dose of suspect TYPHOID VI POLYSACCHARIDE VACCINE (strength, formulation, lot number and expiry date was unknown) via intramuscular route in the left deltoid for Immunization. Information for batch and expiry date was requested.  On 22-Aug-2022 the patient developed a non-serious event of expired typhim vi dose was administered with no other reported adverse event (expired product administered) (Latency: same day) following the administration of TYPHOID VI POLYSACCHARIDE VACCINE.  Action taken: not applicable.  Outcome: Unknown for the event expired product administered  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Pt had severe pain at the injection site at the night of the injection date. Cont. pain till next day. Advise to take some TYLENOL or MOTRIN.
Dizziness; Sore Arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache). At the time of the report, DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
whole body ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 08Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "whole body ache". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Soreness in muscle in left arm where vaccinated - especially when I lift my arm above my shoulder.
Patient presented to emergency department on 6/8/2021 with complaints of abdominal pain and confusion.  She was found to have a urinary tract infection and admitted for further management. She was found to by positive for COVID-19 during routine screening for hospital admission. She has remained asymptomatic for COVID-19 infection during admission. Patient remains admitted at time of writing.
I've noticed that my heart rate has been elevated since my booster shot given on 12/21. I experience breathlessness, heart palpitations, and high heart rate when completing normal, every day activities. My smart watch has noted that my heart rate has been trending higher for 7 weeks, starting 2 days after my booster shot. My resting heart rate has increased by 11 beats per minute.
Redness, inflammation, fever - started day after receiving vaccine. Patient put ice packs on it and took some ibuprofen as well. Was doing fine 2 days later.
Scheduled for surgery; advised not to get second shot from surgeon because the patient was still recovering; This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (Scheduled for surgery) and OFF LABEL USE (advised not to get second shot from surgeon because the patient was still recovering) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2021, the patient experienced OFF LABEL USE (advised not to get second shot from surgeon because the patient was still recovering). On 12-Jan-2021, the patient experienced SURGERY (Scheduled for surgery). On 04-Jan-2021, OFF LABEL USE (advised not to get second shot from surgeon because the patient was still recovering) had resolved. At the time of the report, SURGERY (Scheduled for surgery) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment information was provided.  The patient wanted to know whether the patient had to start the Moderna vaccine series over again or not.
Left arm numbness and tingling, headaches, redness and swelling about 2 inches in diameter around site of injection.
On 9/30, agency was notified by an out-of-state health services company that a nurse had reused syringes for multiple persons earlier that day at an employee influenza vaccination clinic where the health services company had been contracted. The nurse contracted by the health services company brought three multiple-dose vials of vaccine that were intended for another event (and stored in her personal fridge without temp monitoring). The nurse reported using two syringes she found among her supplies to administer vaccine to 67 employees of the business. She reported wiping the syringes with alcohol and using a new needle for each of the 67 persons. Only 2 multiple dose vials of vaccine (10 doses/vial) were used for 67 adult participants. Participants were offered bloodborne pathogen testing (hep B, hep C, HIV), hepatitis B vaccine, and flu vaccine.
got sick - unspecified; This case was reported by a pharmacist via call center representative and described the occurrence of sickness in a 77-year-old female patient who received Herpes zoster (Shingrix) (batch number MX2LT, expiry date 29th May 2021) for prophylaxis.   On 4th February 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced sickness (serious criteria hospitalization). On an unknown date, the outcome of the sickness was unknown.   The reporter considered the sickness to be unrelated to Shingrix.  Additional details were reported as follows: The patient had history of unknown medical condition. The pharmacist reported that after receiving vaccination, the patient got sick due to an unknown medical condition and was hospitalized. This delayed the 2nd dose of Shingrix. The reporter did not know the symptoms experienced by patient but he knewthat those symptoms were related to her medical condition. The reporter did not have any information about the hospitalization.
Narrative: Patient required hospitalization in 11/2021 for initial evaluation and diagnosis. Patient now has persistent severe cardiomyopathy as a result of this event. He has not been able to participate in exercises nor can he over exert. He must now take medication to manage his condition and is currently wearing a life vest, with potential need for placement of defibrillator soon.
Pain starting in the elbow, arthritis pain in elbow area wich runs down to wrist in right arm. Weakness in right arm, constant pain and weakness in right arm
This spontaneous report was received from a healthcare worker who stated that she believed that some patients may have received unspecified doses in the RECOMBIVAXHB immunization series were administered after being improperly stored. No adverse effects reported. The healthcare worker offered some lots that may had been affected: Lot # L016427, expiry date 13-APR-2017, and Lot # L004754, expiry date 10-NOV-2016. The healthcare worker stated that dates of administration were unspecified at the time of this report. Additional information is not expected.
Fever; Chills; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Tiredness) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications were not reported.    Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Significant TCR report received, Reporter's email address added.
Chest pain and shortness of breath following each dose of COVID vaccine lasting for days. Chronic and worsening since third dose now 6 months post vaccination. So far cardiac testing negative, further evaluation is in process.
LEFT ARM (INJECTION SITE) SWELLING, PAIN AND HEADACHES, CHILLS/FEVER
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Systemic: Seizure-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Vomiting-Mild, Additional Details: Within 10mins of vaccine, pt seem to have a mild seizure for less than 30sec. Pt had no hx of seizures, on no current medication. Pt recovered, and within 1-2mins she passed out. She was warm. She woke up within 1min, then started to vomit. Called emergency services. She felt better after throwing up. When ambulance arrived, she started to have tingling sensation on her finger tips. States she felt better. EMT advised her to go to the ER. Pt decided to go to ER to get checked up. Let with ambulance.
Information has been received from a registered nurse concerning a 13 year old male patient who on an unspecified date was vaccinated with a dose of PROQUAD (Merck) (Lot # not provided), "back to school dose required by the state", instead of VARIVAX (Merck0. It was reported that the patient had not experienced any known symptoms. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Headahce, muscle aches, rash on legs and arms, fever 103, nausea, vomiting, delirium, eye ache, breathing difficulty, chills.
Within an hour of receiving the HPV vaccine, pt. developed abdominal pain and nausea.  He vomited that night and throughout the next day.  By 11/12/21 (about 36 hours later), he is feeling a bit better, but still nauseated and with 5/10 abdominal pain.  No fever, no rash, no swelling at injection site, no respiratory symptoms.   No diarrhea. Noone else in household with GI symptoms, and no known exposure to anyone with illness.
Nausea and vomiting around 7:00 P.M. and lightheadedness around 11:00 P.M.
I developed a red arm which was itchy and sore. It started about 10 days after I received the 1st shot. I read on the interenet to ice the sight and take tylenol which eased the symptoms. They disappeared in about four days
PATIENT WAS BEING MONITORED FOR THE 15 MINUTE TIMEFRAME POST VACCINATION. 5 MINUTES INTO MONITORING PATIENT STATES THEY WERE NOT FEELING WELL. FELT NAUSEOUS, HOT, DIZZY, AND THEIR HEARING WAS MUFFLED. WE USED AN ICE PACK PLACED ON THE BACK OF THE NECK FOR THE NEXT 20 MINUTES AND TALKED TO THE PATIENT AND PROVIDED HER A BOTTLE OF WATER. THE SIGNS AND SYMPTOMS SLOWLY RESOLVED OVER THE 20 MINUTES AND PATIENT LEFT ON THEIR OWN ACCORD.
I got Covid-19 during travel. Severe body aches, sever throat pain, lethargic, and inability to care for self.
inconsolable crying x 3hr about 52hr p/vax;tx w/APAP-resolved by following morning;nl exam on 21MAR96;had fever of 101 during crying;